Journey Medical CorporationDERMNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank73
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P73
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$-707000.00+91.6%
2024$-8.40M-537.1%
2023$1.92M+108.3%
2022$-23.18M+29.3%
2021$-32.77M-453.2%
2020$9.28M+44.1%
2019$6.44M+103.1%
2018$-205.54M+30.3%
2017$-294.78M-237.2%
2016$-87.42M-